The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AG-E-83946     1,2,3,4,5-pentachloro-6-(2...

Synonyms: CTK1D6124, AR-1D0537, AC1L3MH1, AC1Q3L2J, 41411-61-4, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of HCB

  • Patients whose hepatitis C (HCV) and hepatitis B (HBV) serostatus was known were classified as being infected by HCV alone, HBV alone (HBsAg positive), both HCV and HBV, or neither HCB nor HBV [1].
  • Thus the considerable sensitisation of the C57BL/10 strain after iron overload to the induction of porphyria by HCB cannot be ascribed simply to enhancement of total metabolism but must be caused either by the formation of a specific undetected metabolite or induction of some other toxic process [2].
  • Liver toxicity is more frequent among subjects with chronic HCV and/or HCB co-infections and alcohol users [3].
  • Beneficial substrate interactions included enhanced degradation of benzene and p-xylene by the presence of toluene in Pseudomonas sp. strain CFS-215 incubations, as well as benzene-dependent degradation of toluene and p-xylene by Arthrobacter sp. strain HCB [4].
  • Pregnant mice were treated with TCDD and either HCB on gestation Days 10 through 13, and the fetuses examined for the presence of cleft palate and renal abnormalities on gestation Day 18 [5].

High impact information on HCB

  • However, anti-P-448HCB inhibited N-hydroxylation by 60% in both 3-MC- and HCB-induced microsomes [6].
  • These results show the hepatic TCDD-binding protein(s) induced upon pretreatment of Sprague-Dawley rats with TCDD/HCB to be kinetically distinct from the Ah receptor, but structurally very similar [7].
  • Glycosylation of the HCB 4,6-O-cyclohexylidenemannoside 5 with primary alcohols was also highly beta-selective, and the HCB 2,3-O-cyclohexylidenemannoside 6 exhibited the moderate beta-selectivity [8].
  • Moreover, P-450 3-dependent steroid 7 alpha-hydroxylase activity was not detected in these extrahepatic tissues of control or HCB-treated rats (less than or equal to 1% of that found in the corresponding liver microsomes of untreated or HCB-treated rats) [9].
  • Since the identification of inducers with such unique characteristics would have implications with regard to the mechanism of induction of all four isozymes, we have examined the induction of cytochromes P-450b and P-450e by HCB and cytochromes P-450c and P-450d by 3-MeO-AAB in liver microsomes from adult male rats [10].

Chemical compound and disease context of HCB


Biological context of HCB


Anatomical context of HCB

  • The adipose tissue content also affected the rate of elimination of HCB [15].
  • Although cytochrome P-448HCB is the predominant cytochrome in liver microsomes from HCB-induced rats, the magnitude of the induction of this isozyme (40-fold) is lower than that of P-448MC (600-fold), because cytochrome P-448HCB is present in higher concentrations in livers of untreated rats than P-448MC (90 versus 3 pmol/mg) [19].
  • In addition, a study on the influence of the chronic exposure to two polyhalogenated hydrocarbons, PCB and HCB, on several parameters of lymphocyte function in mice is presented [20].
  • These results indicate that the effects of HCB on serum testosterone levels reflect its effects on testicular function rather than the pituitary or hypothalamus [21].
  • The significance of the levels of the fungicide HCB in breast milk cannot be determined [22].

Associations of HCB with other chemical compounds


Gene context of HCB

  • We propose that embryotoxicity and retarded embryo growth result from impairment of PR function and that differences in the efficacy of HCB treatments are a result of their dose-dependent, partial estrogenic actions which increase PR Rt via up-regulation of ER [26].
  • As in the human syndrome porphyria cutanea tarda, iron administration increased porphyrin accumulation and the degree of reduction of UROD activity in mice fed HCB [27].
  • Furthermore, animals exposed to HCB and dieldrin, but not to PCB, had a profound decrease in their resistance to a challenge tumor cell implant which was related to a select alteration in tumor cell killing [28].
  • Treatment with HCB did not increase neonatal ethoxyresorufin-O-de-ethylation (EROD) activities whereas a more than 26-fold increase in EROD activity was noted in response to exposure to TCB [24].
  • Analysis of HCB and BHC isomer residues in food [29].

Analytical, diagnostic and therapeutic context of HCB

  • P-450 3 was not detected on Western blots of lung, kidney, or prostate microsomes isolated from control or HCB-treated rats (less than or equal to 2% of that found in livers of HCB-treated rats) [9].
  • Urinary HCB excretion over the next 24 hr, measured by gas chromatography, was 10-fold greater in the group treated with anti-HCB Fab (P < 0.01) [30].
  • The results show a statistically significant decrease in the placental blood flow and an increase in the pulmonary blood flow in the animals fed with 30 mg HCB compared to the control groups [31].
  • Quantitative and qualitative microsocopic fluorescence analysis showed that the cytoplasmic inclusions are formed as early as 3 hr after treatment with HCB [32].
  • Particularly, POPs analytical methods were established using native and (13)C-labeled internal standards of HCHs, HCB, cyclodienes, chlordanes, DDTs, mirex, dioxin-like PCBs, PCDDs, and PCDFs by isotope dilution technique [33].


  1. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. Salmon-Ceron, D., Lewden, C., Morlat, P., Bévilacqua, S., Jougla, E., Bonnet, F., Héripret, L., Costagliola, D., May, T., Chêne, G. J. Hepatol. (2005) [Pubmed]
  2. Fate of hexachlorobenzene in C57BL/10 mice with iron overload. Khanna, R.N., Smith, A.G. Biochem. Pharmacol. (1985) [Pubmed]
  3. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. Núñez, M., Soriano, V. Drug safety : an international journal of medical toxicology and drug experience. (2005) [Pubmed]
  4. Substrate interactions of benzene, toluene, and para-xylene during microbial degradation by pure cultures and mixed culture aquifer slurries. Alvarez, P.J., Vogel, T.M. Appl. Environ. Microbiol. (1991) [Pubmed]
  5. Toxic interaction of specific polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin: increased incidence of cleft palate in mice. Birnbaum, L.S., Weber, H., Harris, M.W., Lamb, J.C., McKinney, J.D. Toxicol. Appl. Pharmacol. (1985) [Pubmed]
  6. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450. Goldstein, J.A., Weaver, R., Sundheimer, D.W. Cancer Res. (1984) [Pubmed]
  7. Characterization of an inducible aryl hydrocarbon receptor-like protein in rat liver. Landers, J.P., Winhall, M.J., McCready, T.L., Sanders, D.A., Rasper, D., Nakai, J.S., Bunce, N.J. J. Biol. Chem. (1991) [Pubmed]
  8. 2-(Hydroxycarbonyl)benzyl glycosides: a novel type of glycosyl donors for highly efficient beta-mannopyranosylation and oligosaccharide synthesis by latent-active glycosylation. Kim, K.S., Kim, J.H., Lee, Y.J., Lee, Y.J., Park, J. J. Am. Chem. Soc. (2001) [Pubmed]
  9. Induction of rat cytochrome P-450 3 and its mRNA by 3,4,5,3',4',5'-hexachlorobiphenyl. Yeowell, H.N., Waxman, D.J., LeBlanc, G.A., Linko, P., Goldstein, J.A. Mol. Pharmacol. (1988) [Pubmed]
  10. Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene. Kelley, M., Hantelle, P., Safe, S., Levin, W., Thomas, P.E. Mol. Pharmacol. (1987) [Pubmed]
  11. Preterm birth in relation to maternal organochlorine serum levels. Torres-Arreola, L., Berkowitz, G., Torres-Sánchez, L., López-Cervantes, M., Cebrián, M.E., Uribe, M., López-Carrillo, L. Annals of epidemiology. (2003) [Pubmed]
  12. Modulation of benzene-induced lymphocytopenia in the rat by 2,4,5,2',4',5'-hexachlorobiphenyl and 3,4,3',4'-tetrachlorobiphenyl. Greenlee, W.F., Irons, R.D. Chem. Biol. Interact. (1981) [Pubmed]
  13. Effect of thyroidectomy and thyroxine on hexachlorobenzene induced porphyria. Sopena de Kracoff, Y.E., Ferramola de Sancovich, A.M., Sancovich, H.A., Kleiman de Pisarev, D.L. J. Endocrinol. Invest. (1994) [Pubmed]
  14. Effects of hexachlorobenzene on phospholipid and porphyrin metabolism in Harderian glands: a time-course study in two strains of rats. Cochón, A.C., San Martín de Viale, L.C., Billi de Catabbi, S.C. Toxicol. Lett. (1999) [Pubmed]
  15. Adipose tissue content as a modifier of the tissue distribution, biological effects, and excretion of a hexachlorobiphenyl in C57BL/6J and DBA/JBOMf mice. Ahotupa, M., Mäntylä, E. Mol. Pharmacol. (1983) [Pubmed]
  16. Toxicity of firemaster FF-1 and 2,2',4,4',5,5'-hexabromobiphenyl in cultures of C3H/10T 1/2 mammalian fibroblasts. Bairstow, F., Hsia, M.T., Norback, D.H., Allen, J.R. Environ. Health Perspect. (1978) [Pubmed]
  17. Effect of hexadecane on the pharmacokinetics of hexachlorobenzene. Scheufler, E., Rozman, K. Toxicol. Appl. Pharmacol. (1984) [Pubmed]
  18. Food web magnificaton of persistent organic pollutants in poikilotherms and homeotherms. Hop, H., Borgá, K., Gabrielsen, G.W., Kleivane, L., Skaare, J.U. Environ. Sci. Technol. (2002) [Pubmed]
  19. Dose response for induction of two cytochrome P-450 isozymes and their mRNAs by 3,4,5,3'4'5'-hexachlorobiphenyl indicating coordinate regulation in rat liver. Hardwick, J.P., Linko, P., Goldstein, J.A. Mol. Pharmacol. (1985) [Pubmed]
  20. Assessment of environmental contaminant-induced lymphocyte dysfunction. Silkworth, J.B., Loose, L.D. Environ. Health Perspect. (1981) [Pubmed]
  21. Suppression of male-specific cytochrome P450 2c and its mRNA by 3,4,5,3',4',5'-hexachlorobiphenyl in rat liver is not causally related to changes in serum testosterone. Yeowell, H.N., Waxman, D.J., LeBlanc, G.A., Linko, P., Goldstein, J.A. Arch. Biochem. Biophys. (1989) [Pubmed]
  22. Organochlorine pesticides in Western Australian nursing mothers. Stevens, M.F., Ebell, G.F., Psaila-Savona, P. Med. J. Aust. (1993) [Pubmed]
  23. Lactational transfer of 2,4,5,2',4',5'-hexachlorobiphenyl but not 3,4,3',4'-tetrachlorobiphenyl, induces neonatal CYP4A1. Borlakoglu, J.T., Henderson, C.J., Wolf, C.R. Biochem. Pharmacol. (1993) [Pubmed]
  24. Lactational transfer of 3,3',4,4'-tetrachloro- and 2,2',4,4',5,5'-hexachlorobiphenyl induces cytochrome P450IVA1 in neonates. Evidence for a potential synergistic mechanism. Borlakoglu, J.T., Clarke, S., Huang, S.W., Dils, R.R., Haegele, K.D., Gibson, G.G. Biochem. Pharmacol. (1992) [Pubmed]
  25. Phenobarbital induction of CYP2B1/2 in primary hepatocytes: endocrine regulation and evidence for a single pathway for multiple inducers. Ganem, L.G., Trottier, E., Anderson, A., Jefcoate, C.R. Toxicol. Appl. Pharmacol. (1999) [Pubmed]
  26. 2,2',4,4',5,5'- and 3,3',4,4',5,5'-hexachlorobiphenyl alteration of uterine progesterone and estrogen receptors coincides with embryotoxicity in mink (Mustela vision). Patnode, K.A., Curtis, L.R. Toxicol. Appl. Pharmacol. (1994) [Pubmed]
  27. Effects of chlorinated organics on intermediates in the heme pathway and on uroporphyrinogen decarboxylase. Cantoni, L., Rizzardini, M., Graziani, A., Carugo, C., Garattini, S. Ann. N. Y. Acad. Sci. (1987) [Pubmed]
  28. Environmental chemical-induced macrophage dysfunction. Loose, L.D., Silkworth, J.B., Charbonneau, T., Blumenstock, F. Environ. Health Perspect. (1981) [Pubmed]
  29. Analysis of HCB and BHC isomer residues in food. Szokolay, A., Uhnák, J., Sackmauerová, M., Madaric, A. J. Chromatogr. (1975) [Pubmed]
  30. Redistribution and enhanced urinary excretion of 2,2',4,4',5,5'-hexachlorobiphenyl (HCB) in rats using HCB-specific IgG and Fab fragments. Keyler, D.E., Goon, D.J., Shelver, W.L., Ross, C.A., Nagasawa, H.T., St Peter, J.V., Pentel, P.R. Biochem. Pharmacol. (1994) [Pubmed]
  31. The influence of 2,2',4,4',5,5'-hexachlorobiphenyl on the placental blood flow in guinea pigs at a late stage of gestation. Hedman, C., Bjellin, L., Mårtensson, L. Environmental research. (1985) [Pubmed]
  32. 2,4,5,2',4',5'-Hexachlorobiphenyl-lipoprotein (LDL, HDL, VLDL) interaction and induced lipidosis in cultured skin fibroblasts. Kling, D., Becker, M.M., Kruth, H.S., Gamble, W. Environmental research. (1984) [Pubmed]
  33. Analysis of UNEP priority POPs using HRGC-HRMS and their contamination profiles in livers and eggs of great cormorants (Phalacrocorax carbo) from Japan. Kumar, K.S., Watanabe, K., Takemori, H., Iseki, N., Masunaga, S., Takasuga, T. Arch. Environ. Contam. Toxicol. (2005) [Pubmed]
WikiGenes - Universities